Of course. Here is the 'Investments' note generated from the trial balance data for the period 'Total Mar'25'.

***

### **GL Level Breakdown for NOTE 5**
**Period: Total Mar'25**

| GL Code | GL Description | Amount (₹) |
|---|---|---|
| 13020030 | Chemoscience Malaysia | 13,45,564 |
| 13020031 | Prov for diminution in value of investment-Chemoscience (M) | (1,29,951) |
| 13020050 | Chemoresources Sdn Bhd | 5,83,720 |
| 13020051 | Prov for diminution in value of investment-Chemoresources | (5,83,720) |
| 13020060 | Chemoinformatics Sdn Bhd | 1,00,000 |
| 13020061 | Prov for diminution in value of investment-Chemoinformatics Sdn Bhd | (99,999) |
| 13020100 | PT CHEMOSCIENCE INDONESIA | 9,90,750 |
| 13020101 | Prov for diminution in value of investment-PT Chemoscience | (9,90,749) |
| 13020150 | Chemoscience Pte Ltd | 1,58,84,598 |
| 13020160 | Chemoscience Phils Inc | 49,47,327 |
| 13020161 | Medigene Sdn Bhd | 1,95,81,141 |
| 13020170 | Scientific Resources Pte Ltd | 2,73,64,808 |
| 13020175 | Research Instruments Pte. Ltd. | 8,13,20,379 |
| 13020180 | Research Instruments Sdn Bhd | 1,50,40,000 |
| 13020190 | Biofrontier Technology Pte Ltd | 5,00,60,697 |
| 13020195 | Hausen Bernstein Co Ltd | 7,08,28,976 |
| **Total:** | | **₹28,68,43,541** |

---

### **NOTE 5: INVESTMENTS**
**Amounts in ₹**

| Particulars | As at 31 March 2025 |
| :--- | ---: |
| **Investments** | |
| | |
| **Investment in subsidiaries** | |
| *Non-current investments (Carried at cost):* | |
| **Investment in unquoted equity instruments – at cost.** | |
| | |
| 5,00,000 equity shares of 1 RM each held in Chemoscience (Malaysia) Sdn. Bhd. | 13,45,564 |
|  Less: Impairment in value of investments | (1,29,951) |
| | |
| 2,00,000 equity shares of 1 RM each held in Chemoresources Sdn. Bhd. | 5,83,720 |
|  Less: Impairment in value of investments | (5,83,720) |
| | |
| 1,00,000 equity shares of 1 RM each held in Chemoinformatics Sdn. Bhd. | 1,00,000 |
|  Less: Impairment in value of investments | (99,999) |
| | |
| 2,989 equity shares of 1 IDR each held in Pt Chemoscience Indonesia | 9,90,750 |
|  Less: Impairment in value of investments | (9,90,749) |
| | |
| 52,15,143 equity shares of 1 SGD each held in Chemoscience Pte. Ltd. | 1,58,84,598 |
| | |
| 2,00,000 equity shares of 100 PHP each held in Chemoscience Phils. Inc. | 49,47,327 |
| | |
| 15,00,000 equity shares of 1 RM each held in Medigene Sdn. Bhd. | 1,95,81,141 |
| | |
| 4,00,000 equity shares of 1 SGD each held in Research Instruments Pte. Ltd. | 8,13,20,379 |
| | |
| 11,77,000 equity shares of 1 RM each held in Research Instruments Sdn. Bhd. | 1,50,40,000 |
| | |
| 50,000 equity shares of 1 SGD each held in Scientific Resources Pte. Ltd. | 2,73,64,808 |
| | |
| 1,00,000 equity shares of 1 SGD each held in Biofrontier Technology Pte. Ltd. | 5,00,60,697 |
| | |
| 19,50,000 equity shares of 100 Baht each held in Hausen Bernstein Co. Ltd. | 7,08,28,976 |
| | |
| **TOTAL INVESTMENTS** | **28,68,43,541** |
| | **═══════════════** |